Your browser doesn't support javascript.
loading
PD-1 and LAG-3 Dominate Checkpoint Receptor-Mediated T-cell Inhibition in Renal Cell Carcinoma.
Zelba, Henning; Bedke, Jens; Hennenlotter, Jörg; Mostböck, Sven; Zettl, Markus; Zichner, Thomas; Chandran, Anoop; Stenzl, Arnulf; Rammensee, Hans-Georg; Gouttefangeas, Cécile.
Afiliação
  • Zelba H; Department of Immunology, University of Tübingen, Tübingen, Germany. henning_zelba@gmx.de cecile.gouttefangeas@uni-tuebingen.de.
  • Bedke J; Department of Urology, University Hospital Tübingen, Tübingen, Germany.
  • Hennenlotter J; Department of Urology, University Hospital Tübingen, Tübingen, Germany.
  • Mostböck S; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Zettl M; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Zichner T; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Chandran A; Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Stenzl A; Department of Urology, University Hospital Tübingen, Tübingen, Germany.
  • Rammensee HG; Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Gouttefangeas C; Department of Immunology, University of Tübingen, Tübingen, Germany. henning_zelba@gmx.de cecile.gouttefangeas@uni-tuebingen.de.
Cancer Immunol Res ; 7(11): 1891-1899, 2019 Nov.
Article em En | MEDLINE | ID: mdl-31484656

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Antígenos CD / Subpopulações de Linfócitos T / Linfócitos do Interstício Tumoral / Receptor de Morte Celular Programada 1 / Neoplasias Renais Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Antígenos CD / Subpopulações de Linfócitos T / Linfócitos do Interstício Tumoral / Receptor de Morte Celular Programada 1 / Neoplasias Renais Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2019 Tipo de documento: Article